Literature DB >> 12135329

Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients: implications for early atherosclerosis.

Tomoo Furumoto1, Naotaka Saito, Jie Dong, Taisei Mikami, Satoshi Fujii, Akira Kitabatake.   

Abstract

Although hypertension, hyperlipidemia, diabetes and smoking are known risk factors of atherosclerosis in Caucasians, their relative contributions to early atherosclerosis among Japanese are unknown. Decrease in flow-mediated dilation (FMD) of the brachial artery is a useful marker of endothelial dysfunction and early atherosclerosis. To evaluate the relative contribution of hypertension to early atherogenesis, we determined FMD, as well as plasma levels of tissue-type plasminogen activator (t-PA; a sensitive index of endothelial damage) and tumor necrosis factor (TNF)-a and interleukin (IL)-6 (established markers of inflammation) in normotensive and hypertensive patients under treatment. FMD was significantly reduced as the number of risk factors increased, suggesting that accumulations of risk factors were related to endothelial dysfunction. FMD was reduced in hypertensives (9.9 +/- 5.8 (SD) %) compared to normotensives (14.6 +/- 7.6, p<0.01) despite good blood pressure control (139 +/- 20/80 +/- 14 mmHg in hypertensives). Nitroglycerine-induced endothelium-independent vasodilation was not altered in hypertensives (16.0 +/- 6.3%) as compared to normotensives (16.7 +/- 5.8). Plasma t-PA, TNF-alpha, and IL-6 levels were increased in hypertensives despite good blood pressure control. Thus, hypertension alone is a high risk for early atherosclerosis. Persistent endothelial damage and moderate inflammation may increase the risk of early atherosclerosis synergistically under the presence of hypertension in Japanese.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135329     DOI: 10.1291/hypres.25.475

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  19 in total

1.  Gingival Fluid Inflammatory Biomarkers and Hypertension in African Americans.

Authors:  A Khocht; T Rogers; M N Janal; M Brown
Journal:  JDR Clin Trans Res       Date:  2017-02-01

2.  Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.

Authors:  Oliver Dörr; Christoph Liebetrau; Helge Möllmann; Felix Mahfoud; Sebastian Ewen; Luise Gaede; Christian Troidl; Jedrzej Hoffmann; Nikolai Busch; Gerald Laux; Jens Wiebe; Timm Bauer; Christian Hamm; Holger Nef
Journal:  Clin Res Cardiol       Date:  2014-10-18       Impact factor: 5.460

Review 3.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 4.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

5.  Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.

Authors:  Michael R Flock; Ann C Skulas-Ray; William S Harris; Trent L Gaugler; Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-07-17       Impact factor: 4.006

6.  Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients.

Authors:  Emin Alioglu; Ugur O Turk; Firat Bicak; Istemihan Tengiz; Dincer Atila; Vatan Barisik; Ertugrul Ercan; Mustafa Akin
Journal:  Clin Res Cardiol       Date:  2008-03-17       Impact factor: 5.460

7.  Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

Authors:  Cevad Sekuri; Ozgur Bayturan; Hakan Gocer; Talat Tavli; Ugur Kemal Tezcan
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

8.  Tumor necrosis factor α decreases nitric oxide synthase type 3 expression primarily via Rho/Rho kinase in the thick ascending limb.

Authors:  Vanesa D Ramseyer; Nancy J Hong; Jeffrey L Garvin
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

Review 9.  Hypertension and aging.

Authors:  Thomas W Buford
Journal:  Ageing Res Rev       Date:  2016-02-01       Impact factor: 10.895

10.  Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol.

Authors:  Xiao Sun; Man Zhang; Akimasa Sanagawa; Chieko Mori; Shiori Ito; Soichiro Iwaki; Hiroki Satoh; Satoshi Fujii
Journal:  Thromb J       Date:  2012-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.